v2.2
Contact
News
Diagnosing DIRD
Browse
Available on AppStore
The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Dijon, France
Browse by »
Drugs
Patterns
Nivolumab
5
IX.ab
Guillain-Barré (or GB-like) syndrome (w/wo ARF)
1
Last update :
11/03/2019
Search
Search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Avelumab
Durvalumab
Immune checkpoint inhibitors (ICI) - ICI combinatorial Rx
Lambrolizumab
PD-1/PD-L1-inhibitors or blocking agents/drugs
Pembrolizumab
Publications
Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.